Actual Medicinal Product (AMP) Apixaban 2.5mg tablets (Umedica Laboratories UK Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
No special precautions for storage.
- Provenance
-
This compatibility recommendation is derived from Eliquis 2.5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd).
- Generic
- Apixaban
- Formulation
- Apixaban 2.5mg tablets
-
Apixaban
-
Apixaban 2.5mg tablets
-
Apixaban 2.5mg tablets (Umedica Laboratories UK Ltd)
-
-
Apixaban 5mg tablets